KNOWLEDGE, ATTITUDE, AND PERCEPTION OF NURSES AND PHYSICIANS REGARDING PHARMACEUTICAL-INITIATED CLINICAL RESEARCH IN UAE, QATAR, OMAN, BAHRAIN, AND JORDAN
Objective: The objective of the study was to understand the reasons for the limited number of pharmaceutical-initiated clinical studies in the Middle East region, by assessing the knowledge, attitudes, and perceptions related to pharmaceutical-initiated clinical trials among health-care professionals (HCPs) in UAE, Qatar, Oman, Bahrain, and Jordan.
Methods: The study was conducted using an online questionnaire-based survey. The HCP respondents were from UAE, Qatar, Oman, Bahrain, and Jordan and had a good understanding of the English language. Descriptive statistical analysis was used to analyze the responses.
Results: The HCPs were not inclined toward participation in clinical trials and research activities. The reasons for their limited participation included a lack of time, resources, and limited awareness about their legal protection associated with such studies, and the lack of necessary training and education related to clinical research.
Conclusions: Although there is a willingness to participate in clinical trials conducted by pharmaceutical companies, HCPs face various ethical, administrative, and academic barriers. Addressing these issues would help increase the number of trials conducted in the Middle East region.
2. Nair S, Ibrahim H, Celentano D. Clinical trials in the Middle East and North Africa (MENA) region: Grandstanding or grandeur? Contemp Clin Trials 2013;36:704-10.
3. Watch News Online. Available from: http://www.centerwatch.com/news-online/2011/10/24/middle-east-region-poised-for-clinical-trials-growth. [Last accessed on 2017 Nov 12].
4. Mitwalli HA, Al Ghamdi KM, Moussa NA. Perceptions, attitudes, and practices towards research among resident physicians in training in Saudi Arabia. East Mediterr Health J 2014;20:99-104.
5. Sulthan N. Perception of clinical research among clinical investigators in Saudi Arabia. Asian J Pharm Clin Res 2015;8:243-6.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.